Published in Thromb Res on January 01, 1979
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest (1999) 5.65
Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest (2005) 2.46
PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol (2000) 1.36
Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit. FASEB J (2009) 1.00
Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis. J Exp Med (2002) 0.98
A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties. Blood (2005) 0.84
Intravenous hemostats: challenges in translation to patients. Nanoscale (2013) 0.79
PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis. Cardiovasc Hematol Agents Med Chem (2012) 0.75
MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis. PLoS Pathog (2016) 0.75
Platelet-vessel wall interactions in hemostasis: implication of 5-hydroxytryptamine. Agents Actions (1984) 0.75
Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury. Purinergic Signal (2017) 0.75
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell (1999) 7.33
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet (2001) 6.38
Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol (1998) 5.32
Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest (1997) 3.93
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci (1998) 3.80
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A (1999) 3.49
The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol (1995) 3.27
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet (1978) 3.15
Cytokine regulation of endothelial cell function. FASEB J (1992) 3.00
Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood (1996) 2.94
IL-1 stimulates IL-6 production in endothelial cells. J Immunol (1989) 2.85
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood (1996) 2.76
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol (1994) 2.63
Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today (1989) 2.60
Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol Chem (1995) 2.40
Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol (1995) 2.25
Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem (2000) 2.13
Prostacyclin synthesis induced in vascular cells by interleukin-1. Science (1985) 2.13
Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol (1990) 2.10
Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol (1998) 2.08
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci (1997) 2.01
Regulation of the VLA integrin-ligand interactions through the beta 1 subunit. J Cell Biol (1992) 1.96
Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context. Mol Biol Cell (1999) 1.94
Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol (1997) 1.94
Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol (1996) 1.90
The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol (1991) 1.85
Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A (1997) 1.84
Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol (1999) 1.81
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest (1985) 1.79
Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol (1996) 1.78
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res (1990) 1.77
X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J (2001) 1.75
Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med (1993) 1.72
Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol (1994) 1.70
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro. J Cell Biol (1987) 1.59
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest (1986) 1.57
Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. Arterioscler Thromb Vasc Biol (2000) 1.57
Evidence that vascular endothelial cells can induce the retraction of fibrin clots. Proc Soc Exp Biol Med (1981) 1.51
Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J Exp Med (1991) 1.51
Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J Clin Invest (1996) 1.49
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology (1990) 1.47
Interendothelial junctions: structure, signalling and functional roles. Curr Opin Cell Biol (1997) 1.46
The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice. Blood (1999) 1.45
CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood (1993) 1.44
Prostacyclin and human foetal circulation. Prostaglandins (1979) 1.42
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
Modulation of vitronectin receptor binding by membrane lipid composition. J Biol Chem (1990) 1.38
Homophilic interaction of junctional adhesion molecule. J Biol Chem (2000) 1.37
Molecules involved in the adhesion and cytotoxicity of activated monocytes on endothelial cells. J Immunol (1992) 1.36
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
Identification and characterisation of human Junctional Adhesion Molecule (JAM). Mol Immunol (1999) 1.29
Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res (2000) 1.27
Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet (1982) 1.27
Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb Res (1979) 1.26
Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J Biol Chem (2000) 1.21
Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol (1994) 1.19
Interaction of fibronectin with cultured human endothelial cells: characterization of the specific receptor. Blood (1989) 1.18
Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood (2001) 1.17
Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood (1992) 1.17
Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis (2009) 1.15
VE-cadherin and desmoplakin are assembled into dermal microvascular endothelial intercellular junctions: a pivotal role for plakoglobin in the recruitment of desmoplakin to intercellular junctions. J Cell Sci (1998) 1.15
Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res (1977) 1.14
Platelet hyperaggregability and the nephrotic syndrome. Thromb Res (1979) 1.12
Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells. J Natl Cancer Inst (1991) 1.11
Endothelial adhesion molecules in the development of the vascular tree: the garden of forking paths. Curr Opin Cell Biol (1999) 1.11
Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol (1996) 1.09
Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol (1998) 1.09
Immunoelectron characterisation of the inter-endothelial junctions of human term placenta. J Cell Sci (1993) 1.07
Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost (2001) 1.07
An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J Cell Biol (1991) 1.05
Familial deficiency of a plasma factor stimulating vascular prostacyclin activity. Thromb Res (1979) 1.05
Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost (1982) 1.05
Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet (1981) 1.05
Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res (1995) 1.04
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res (1991) 1.03
Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis. Thromb Haemost (1994) 1.03
Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica (1992) 1.02
IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. J Immunol (1988) 1.02
Modulation of endothelial cell functions by different molecular species of interleukin 1. Blood (1987) 1.01
A novel mechanism of colon carcinoma cell adhesion to the endothelium triggered by beta 1 integrin chain. J Biol Chem (1994) 1.01
Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis. Rev Eur Etud Clin Biol (1970) 1.00
Desmoplakin expression and organization at human umbilical vein endothelial cell-to-cell junctions. J Cell Sci (1996) 1.00
Treatment of the hemolytic uremic syndrome with plasma. Clin Nephrol (1979) 0.99
Pores in the sieve and channels in the wall: control of paracellular permeability by junctional proteins in endothelial cells. Microcirculation (2001) 0.99
Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas. J Pathol (1995) 0.98
Typical breakfast food consumption and risk factors for cardiovascular disease in a large sample of Italian adults. Nutr Metab Cardiovasc Dis (2010) 0.98